Sort
30,917 grants matching “tumor microenvironment”
Metabolic alterations in advanced Breast Cancer and response to systemic therapy.
$474,987David Mark Hockenbery · Fred Hutchinson Cancer Research Center · P50 · FY2012 · CA
Co-targeting the HER3 oncogenic signaling circuitry and PD-1 as a novel multimodal precision immunotherapy for HNSCC
$474,976J. Silvio Gutkind · University Of California, San Diego · R01 · FY2024 · CA
Mucosal T cell memory to pathogens
$474,940David Masopust · University Of Minnesota · R01 · FY2020 · AI
Immune biological differences between Triple Negative Breast Cancer in African American and non-African American women and potential immunotherapy opportunities to improve treatment outcome
$474,931Lajos Pusztai · Yale University · R01 · FY2020 · CA
Engineering bZIP family transcription factors for therapeutic T-cell persistence and effector function
$474,924Glenna Wink Foight · Baylor College Of Medicine · R37 · FY2025 · CA
Hepatic stellate cells in NASH fibrosis and HCC
$474,893Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
DEVELOPMENTAL FUNDS
$474,877Paul A Bunn · University Of Colorado Denver · P30 · FY2015 · CA
Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance
$474,833Joe W. Gray · Oregon Health & Science University · U54 · FY2017 · CA
Differential metabolic network analysis of tumor progression
$474,827James P Freyer · Los Alamos Nat Secty-Los Alamos Nat Lab · R01 · FY2007 · CA
Therapeutic targeting of glutamine metabolism in MDS
$474,750Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Oncogenic Kit receptor signaling in vivo
$474,750Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2010 · HL
Functional Cooperation of Tissue Factor and Integrins
$474,750Wolfram Ruf · Scripps Research Institute, The · R01 · FY2011 · HL
Functional Cooperation of Tissue Factor and Integrins
$474,750Wolfram Ruf · Scripps Research Institute, The · R01 · FY2010 · HL
Functional Cooperation of Tissue Factor and Integrins
$474,750Wolfram Ruf · Scripps Research Institute, The · R01 · FY2009 · HL
Functional Cooperation of Tissue Factor and Integrins
$474,750Wolfram Ruf · Scripps Research Institute, The · R01 · FY2012 · HL
Oncogenic Kit receptor signaling in vivo
$474,750Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2009 · HL
Combating Subclonal Evolution of Resistant Cancer Phenotypes
$474,644Andrea Hope Bild · University Of Utah · U54 · FY2017 · CA
Hydrogel-Based Cytokine Carrier for Oral cancer Therapy
$474,640New York University · R01 · FY2005 · DE
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
$474,621Guangwen Ren · Jackson Laboratory · R01 · FY2023 · CA
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
$474,620Guangwen Ren · Jackson Laboratory · R01 · FY2022 · CA
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
$474,565Robert J Coffey · Vanderbilt University Medical Center · U54 · FY2022 · CA
Targeting Metabolic Vulnerabilities of Triple Negative Breast Cancer Stem Cells
$474,547Max S. Wicha · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Targeting Metabolic Vulnerabilities of Triple Negative Breast Cancer Stem Cells
$474,547Max S. Wicha · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Molecular mechanisms and therapeutic principles of VISTA+ triple-negative breast cancers
$474,511Joshua James Gruber · Ut Southwestern Medical Center · R01 · FY2024 · CA
Stromal Fibroblast Autophagy In Tumor Progression and Desmoplasia
$474,424Jayanta Debnath · University Of California, San Francisco · R01 · FY2019 · CA